Temporal changes in N-acylethanolamine content and metabolism throughout the peri-adolescent period

Synapse

Volumn 67, Issue 1, 2013, Pages 4-10

  Lee, Tiffany T Y ^a   Hill, Matthew N ^b   Hillard, Cecilia J ^c   Gorzalka, Boris B ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Adolescence; Adolescent development; Anandamide; Corticolimbic circuit; Endocannabinoid; Fatty acid amide hydrolase; Oleoylethanolamine; Palmitoylethanolamide

Indexed keywords

ANANDAMIDE; ENDOCANNABINOID; FATTY ACID AMIDASE; N OLEOYLETHANOLAMINE; PALMIDROL;

ADOLESCENCE; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN METABOLISM; CONTROLLED STUDY; DEVELOPMENTAL STAGE; EMOTIONALITY; ENZYME ACTIVITY; HIPPOCAMPUS; HYPOTHALAMUS; MALE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SPRAGUE DAWLEY RAT; STRESS; TEMPORAL CORTEX;

AGE FACTORS; AMIDOHYDROLASES; ANIMALS; ARACHIDONIC ACIDS; ENDOCANNABINOIDS; ETHANOLAMINES; LIMBIC SYSTEM; MALE; POLYUNSATURATED ALKAMIDES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84870319187     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.21609     Document Type: Article

References (51)

1. Ahn K, McKinney M, Cravatt B. 2008. Enzymatic pathways that regulate endo-cannabinoid signaling in the nervous system. Chem Rev 108: 1687-1707.
2. Berrendero F, Sepe N, Ramos JA, Di Marzo V, Fernandez-Ruiz JJ. 1999. Analysis of cannabinoid receptor binding and mRNA expression and endogenous cannabinoid contents in the developing rat brain during late gestation and early postnatal period. Synapse 33: 181-191.
3. Casey BJ, Jones RM, Somerville LH. 2011. Braking and accelerating of the adolescent brain. J Res Adolesc 21: 21-33.
4. Chiang K, Gerber AL, Sipe JC, Cravatt BF. 2004. Reduced cellular expression and activity of the P129T mutant of human fatty acid amide hydrolase: Evidence for a link between defects in the endocannabinoid system and problem drug use. Hum Mol Genet 13: 2113-2119.
5. De Petrocellis L, Di Marzo V. 2009. An introduction to the endocannabinoid system: From the early to the latest concepts. Best Pract Res. Clin Endocrinol Metab 23: 1-15.
6. Di Marzo V. 2011. Endocannabinoid signaling in the brain: Biosynthetic mechanisms in the limelight. Nat Neurosci 14: 9-15.
7. Ellgren M, Artmann A, Tkalych O, Gupta A, Hansen HS, Hansen SH, Devi LA, Hurd YL. 2008. Dynamic changes of the endogenous cannabinoid and opioid mesocorticolimbic systems during adolescence: THC effects. Eur Neuropsychopharmacol 18: 826-834.
8. Fu J, Gaetani S, Oveisi F, Lo Verme J, Serrano A, Rodríguez de Fonseca F, Rosengarth A, Luecke H, Di Giacomo B, Tarzia G, Piomelli D. 2003. Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha. Nature 425: 90-93.
9. Gogtay N, Giedd JN, Lusk L, Hayashi KM, Greenstein D, Vaituzis AC, Nugent TF, Herman DH, Clasen LS, Toga AW, Rapoport JL, Thompson PM. 2004. Dynamic mapping of human cortical development during childhood through early adulthood. Proc Natl Acad Sci 101: 8174-8179.
10. Gogtay N, Nugent TF3rd, Herman DH, Ordonez A, Greenstein D, Hayashi KM, Clasen L, Toga AW, Giedd JN, Rapoport JL, Thompson PM. 2006. Dynamic mapping of normal human hippocampal development. Hippocampus 16: 664-672.
11. Hansen H. 2010. Palmitoylethanolamide and other anandamide congeners. Proposed role in the diseased brain. Exp Neurol 224: 48-55.
12. Hariri A, Gorka A, Hyde LW, Kimak M, Halder I, Ducci F, Ferrell RE, Goldman D, Manuck SB. 2009. Divergent effects of genetic variation in endocannabinoid signaling on human threat- and reward-related brain function. Biol Psychiatr 66: 9-16.
13. Harkany T, Keimpema E, Barabás K, Mulder J. 2008. Endocannabinoid functions controlling neuronal specification during brain development. Mol Cell Endocrinol 286: S84-S90.
14. Hill M, Tasker J. 2012. Endocannabinoid signaling, glucocorticoid-mediated negative feedback, and regulation of the hypothalamic-pituitary-adrenal axis. Neuroscience 204: 5-16.
15. Hill M, Karacabeyli E, Gorzalka BB. 2007. Estrogen recruits the endocannabinoid system to modulate emotionality. Psychoneuroendocrinology 32: 350-357.
16. Hill M, Karatsoreos IN, Hillard CJ, McEwen BS. 2010. Rapid elevations in limbic endocannabinoid content by glucocorticoid hormones in vivo. Psychoneuroendocrinology 35: 1333-1338.
17. Hill M, Kumar SA, Filipski SB, Iverson M, Stuhr KL, Keith JM, Cravatt BF, Hillard CJ, Chattarji S, McEwen BS. Disruption of fatty acid amide hydrolase activity prevents the effects of chronic stress on anxiety and amygdalar microstructure. Mol Psychiatr (in press).
18. Hillard C, Wilkison D, Edgemond WS, Campbell WB. 1995. Characterization of the kinetics and distribution of N-arachidonylethanolamine (anandamide) hydrolysis by rat brain. Biochim Biophys Acta 1257: 249-256.
19. Howlett A, Mukhopadhyay S. 2000. Cellular signal transduction by anandamide and 2-arachidonoylglycerol. Chem Phys Lipids 108: 53-70.
20. Kathuria S, Gaetani S, Fegley D, Valiño F, Duranti A, Tontini A, Mor M, Tarzia G, La Rana G, Calignano A, Giustino A, Tattoli M, Palmery M, Cuomo V, Piomelli D. 2003. Modulation of anxiety through blockade of anandamide hydrolysis. Nat Med 9: 76-81.
21. Kinsey S, O'Neal S, Long JZ, Cravatt BF, Lichtman AH. 2011. Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay. Pharmacol Biochem Behav 98: 21-27.
22. Lee T, Gorzalka B. 2012. Timing is everything: Evidence for a role of corticolimbic endocannabinoids in modulating hypothalamic-pituitary-adrenal axis activity across developmental periods. Neuroscience 204: 17-30.
23. Leung D, Saghatelian A, Simon GM, Cravatt BF. 2006. Inactivation of N-acyl phosphatidylethanolamine phospholipase D reveals multiple mechanisms for the biosynthesis of endocannabinoids. Biochemistry 45: 4720-4726.
24. Lo Verme J, Fu J, Astarita G, La Rana G, Russo R, Calignano A, Piomelli D. 2005. The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide. Mol Pharmacol 67: 15-19.
25. Maccarrone M, De Felici M, Bari M, Klinger F, Siracusa G, Finazzi-Agro A. 2000. Down-regulation of anandamide hydrolase in mouse uterus by sex hormones. Eur J Biochem 267: 2991-2997.
26. Mahler S, Smith K, Berridge KC. 2007. Endocannabinoid hedonic hotspot for sensory pleasure: Anandamide in nucleus accumbens shell enhances 'liking' of a sweet reward. Neuropsychopharmacology 32: 2267-2278.
27. McCormick CM, Mathews IZ, Thomas C, Waters P. 2010. Investigations of HPA function and the enduring consequences of stressors in adolescence in animal models. Brain Cogn 72: 73-85.
28. Moesgaard B, Petersen G, Jaroszewski JW, Hansen HS. 2000. Age dependent accumulation of N-acyl-ethanolamine phospholipids in ischemic rat brain. A (31)P NMR and enzyme activity study. J Lipid Res 41: 985-990.
29. Moreira F, Aguiar D, Terzian AL, Guimarães FS, Wotjak CT. 2012. Cannabinoid type 1 receptors and transient receptor potential vanilloid type 1 channels in fear and anxiety-two sides of one coin? Neuroscience 204: 186-192.
30. Morishita J, Okamoto Y, Okamoto Y, Tsuboi K, Ueno M, Sakamoto H, Maekawa N, Ueda N. 2005. Regional distribution and age-dependent expression of N-acylphosphatidylethanolamine-hydrolyzing phospholipase D in rat brain. J Neurochem 94: 753-762.
31. Omeir R, Chin S, Chin S, Hong Y, Ahern DG, Deutsch DG. 1995. Arachidonoyl ethanolamide-[1, 2-14C] as a substrate for anandamide amidase. Life Sci 56: 1999-2005.
32. Overton H, Babbs A, Doel SM, Fyfe MC, Gardner LS, Griffin G, Jackson HC, Procter MJ, Rasamison CM, Tang-Christensen M, Widdowson PS, Williams GM, Reynet C. 2006. Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents. Cell Metab 3: 167-175.
33. Patel S, Rademacher D, Hillard C. 2003. Differential regulation of the endocannabinoids anandamide and 2-arachidonylglycerol within the limbic forebrain by dopamine receptor activity. J Pharmacol Exp Ther 306: 880-888.
34. Patel S, Carrier EJ, Vannesa Ho W-S, Rademacher DJ, Cunningham S, Sudarshan Reddy D, Falck JR, Cravatt BF, Hillard CJ. 2005. The postmortal accumulation of brain N-arachidonylethanolamine (anandamide) is dependent upon fatty acid amide hydrolase activity. J Lipid Res 46: 342-349.
35. Pattij T, Janssen M, Janssen MC, Schepers I, Gonzalez-Cuevas G, de Vries TJ, Schoffelmeer AN. 2007. Effects of the cannabinoid CB1 receptor antagonist rimonabant on distinct measures of impulsive behavior in rats. Psychopharmacology 193: 85-96.
36. Pattwell S, Bath K, Casey BJ, Ninan I, Lee FS. 2011. Selective early-acquired fear memories undergo temporary suppression during adolescence. Proc Natl Acad Sci 108: 1182-1187.
37. Romeo R. 2010. Adolescence: A central event in shaping stress reactivity. Dev Psychobiol 52: 244-253.
38. Romeo R, Lee S, Chhau N, McPherson CR, McEwen BS. 2004. Testosterone cannot activate an adult-like stress response in prepubertal male rats. Neuroendocrinology 79: 125-132.
39. Romeo R, Bellani R, Karatsoreos IN, Chhua N, Vernov M, Conrad CD, McEwen BS. 2006. Stress history and pubertal development interact to shape hypothalamic-pituitary-adrenal axis plasticity. Endocrinology 147: 1664-1674.
40. Rossi S, De Chiara V, Musella A, Sacchetti L, Cantarella C, Castelli M, Cavasinni F, Motta C, Studer V, Bernardi G, Cravatt BF, Maccarrone M, Usiello A, Centonze D. 2010. Preservation of striatal cannabinoid CB1 receptor function correlates with the antianxiety effects of fatty acid amide hydrolase inhibition. Mol Pharmacol 78: 260-268.
41. Scorticati C, Mohn C, De Laurentiis A, Vissio P, Fernández-Solari J, Seilicovich A, McCann SM, Rettori V. 2003. The effect of anandamide on prolactin secretion is modulated by estrogen. Proc Natl Acad Sci 100: 2134-2139.
42. Sipe JC, Scott TM, Murray S, Harismendy O, Simon GM, Cravatt BF, Waalen J. 2010. Biomarkers of endocannabinoid system activation in severe obesity. PLoS One 5: e8792.
43. Solinas M, Goldberg S, Piomelli D. 2008. The endocannabinoid system in brain reward processes. Br J Pharmacol 154: 369-383.
44. Spear L. 2000. The adolescent brain and age-related behavioral manifestations. Neurosci Behav Rev 24: 417-463.
45. Spear L, Brake S. 1983. Periadolescence: Age-dependent behavior and psychopharmacological responsivity in rats. Dev Psychobiol 16: 83-109.
46. Thomas EA, Cravatt BF, Danielson PE, Gilula NB. 1997. Fatty acid amide hydrolase, the degradative enzyme for anandamide and oleamide, has selective distribution in neurons within the rat central nervous system. J Neurosci Res 50: 1047-1052.
47. Ueda N, Tsuboi K, Uyama T. 2010. Enzymological studies on the biosynthesis of N-acylethanolamines. Biochim Biophys Acta 1801: 1274-1285.
48. Wenger T, Croix D, Tramu G. 1988. The effect of chronic prepubertal administration of marihuana (delta-9-tetrahydrocannabinol) on the onset of puberty and the postpubertal reproductive functions in female rats. Biol Reprod 39: 540-545.
49. Wenger T, Gerendai I, Fezza F, González S, Bisogno T, Fernandez-Ruiz J, Di Marzo V. 2002. The hypothalamic levels of the endocannabinoid, anandamide, peak immediately before the onset of puberty in female rats. Life Sci 70: 1407-1414.
50. Wiskerke J, Stoop N, Schetters D, Schoffelmeer ANM, Pattij T. 2011. Cannabinoid CB1 receptor activation mediates the opposing effects of amphetamine on impulsive action and impulsive choice. PLoS One 6: e25856.
51. Zanettini C, Panlilio L, Alicki M, Goldberg SR, Haller J, Yasar S. 2011. Effects of endocannabinoid system modulation on cognitive and emotional behavior. Front Behav Neurosci 5: 57.